Reglan Lawsuit
Metoclopramide Tardive Dyskinesia Reglan Lawsuits
Patients and families throughout the United States have recently looked at filing a Reglan lawsuit based on the serious side effects from Reglan or being part of a Reglan class action lawsuit. Only recently has the public become aware of the link between Reglan drug side effects and the symptoms that many people have been suffering from, but did not relate to the Reglan medication. Currently we are continuing to file claims individually on behalf of people who have suffered from tardive dyskinesia side effects of Reglan. There currently is no cure for tardive dyskinesia.
Recently published studies suggest that metoclopramide is the most common cause of drug-induced movement disorders. Another analysis of study data by the FDA showed that around 20 percent of patients in that study who used metoclopramide took it for longer than three months. The FDA has also become aware of continued spontaneous reports of metoclopramide tardive dyskinesia in patients who used the drug, the majority of whom had taken the drug for more than the recommended maximum time of three months.
The Reglan lawsuits claim that the various metoclopramide drug manufacturers were negligent in several ways including but not limited to:
- Represented that Reglan / metoclopramide caused minimal side effects of knowing that the drug causes central nervous system side effects like tardive dyskinesia far more frequently than represented
- Had actual knowledge through both their own studies and independent studies, that doctors frequently prescribed Reglan / metoclopramide for long term use that was not safe for patients
- Had actual knowledge that the risk of tardive dyskinesia and other side effects of Reglan / metoclopramide in patients who received the drug for 12 weeks or longer is approximately 100 times greater than disclosed in packaging inserts for Reglan and the Physicians Desk Reference label for the Reglan brand metoclopramide.
- Failed to investigate the accuracy of its Reglan / metoclopramide label once it became aware of signals indicating a safety issue
- Failed to monitor all relevant scientific literature related to Reglan / metoclopramide
- Failed to conduct and report post market safety surveillance on Reglan / metoclopramide
- Reglan / metoclopramide was not reasonably safe as designed because the foreseeable risks involved in its use outweighed the therapeutic benefits of the drug
We represent all clients suffering side effects from Reglan including metoclopramide tardive dyskinesia on a contingency basis which means that there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please call toll free at 1-888-343-5375 or fill out our short online contact form and a Reglan attorney will contact you to answer any of your questions.

